« Previous
Next »
Gastroenterology
Volume 137, Issue 3
, Pages 834-840.e3
, September 2009
Analysis of HLA and Non-HLA Alleles Can Identify Individuals at High Risk for Celiac Disease
References
- . Recent advances in celiac disease. Gut. 2006;7:1037–1046
- . The changing clinical presentation of celiac disease. Arch Dis Child. 2006;12:969–971
- . The changing face of celiac disease. Arch Dis Child. 2006;12:955–956
- European multi-centre study on celiac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol. 2006;2:187–194
- Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology. 2006;2:202–217
- . Translational mini-review series on the immunogenetics of gut disease: immunogenetics of celiac disease. Clin Exp Immunol. 2008;2:162–173
- Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet. 2008;4:395–402
- A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet. 2007;7:827–829
- Celiac disease associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling. Gut. 2009 Feb 24;[Epub ahead of print]
- Revised criteria for diagnosis of celiac disease (Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition). Arch Dis Child. 1990;8:909–911
- Six new celiac disease loci replicated in an Italian population confirm association to celiac disease. J Med Genet. 2008;46:60–63
- . Celiac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;9:647–655
- . Natural history of celiac disease. In: Fasano A, Troncone R, Branski D editor. Frontiers in celiac disease. Basel: Karger; 2008;p. 12–17
- Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE. 2008;5:e2270
- The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A. 2003;21:12390–12395
- A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol. 1994;2:138–142
- Gene dose effect of the DQB1*0201 allele contributes to severity of celiac disease. Scand J Gastroenterol. 2006;2:191–199
- Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;2:157–172
- . Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;7:928–935
- . Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. 2009;1:43–55
- . Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 2007;17:1520–1528
- . Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease (SIGEP Study Group for Autoimmune Disorders in Celiac Disease). Gastroenterology. 1999;2:297–303
- Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008;359:2767–2777
- . Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol. 2008;8:631–643
- Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet. 2007;6:1284–1288
- Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut. 2009;58:799–804
Conflicts of interest The authors disclose the following: David A. van Heel, Cisca Wijmenga and Ross McManus declare competing financial interests. A patent application by Queen Mary University of London is in progress. The remaining authors disclose no conflicts.
Funding Supported by grants from the Celiac Disease Consortium (an innovative cluster approved by the Netherlands Genomics Initiative and partly funded by the Dutch Government, grant BSIK03009 to CW), the Netherlands Organisation for Scientific Research (NWO-VICI grant 918.66.620 to CW) and KP6 EU grant 036383 (PREVENTCD).
To view this article's video abstract, go to the AGA's YouTube Channel.
PII: S0016-5085(09)00772-0
doi: 10.1053/j.gastro.2009.05.040
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 137, Issue 3
, Pages 834-840.e3
, September 2009

